Company intelligence / Profile preview

Humon

Boston, MA, USA

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Humon was a healthcare technology company that developed the Humon Hex, the first clinically validated wearable to monitor muscle oxygen levels in real-time. Utilizing near-infrared spectroscopy (NIRS), the device provided athletes, researchers, and clinicians with insights into muscle exertion and recovery by measuring muscle oxygen saturation (SmO2). The company was founded out of the MIT Sloan School of Management and aimed to optimize human performance and health through physiological data. In 2020, Humon was acquired by Decathlon, and its technology was integrated into the sporting goods giant's digital ecosystem.

Therapeutic areas: CardiovascularNeurologyOther
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Decathlon

Beyond the preview

Go deeper on Humon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Humon.

Explore the full profile